Refine
Year of publication
- 2022 (2)
Document Type
- Article (1)
- Part of a Book (1)
Language
- English (2)
Has Fulltext
- yes (2)
Is part of the Bibliography
- no (2)
Keywords
- Ausgrenzung (1)
- PBBM (1)
- Rassismus (1)
- Rhetorik (1)
- Tiere <Motiv> (1)
- Wolf <Motiv> (1)
- biorelevant dissolution (1)
- clinically relevant dissolution specifications (1)
- oral drug products (1)
- product performance (1)
Institute
- Medizin (1)
Jobst Paul proposes an approach to teaching HAS that develops learners' ability to understand and evaluate how representations of animals may function as vehicles for racism, antisemitism, and other dehumanizing ideologies that are based on modes of thinking that provide justifications for animal death, suffering, and exploitation. As Paul notes in "The Philosophical Animal Deconstructed: From Linguistic to Curricular Methodology," the animals that appear in Western philosophical and theological traditions have been disconnected from their referents and have primarily served various human purposes, for example, as figures of thought. Analyzing representations of wolves in the 2019 election campaign by Alternative für Deutschland (AfD), a right-wing German political party, Paul demonstrates how animals have been used to stigmatize and marginalize vulnerable populations such as refugees, and how these stereotypes have, in turn, been instrumental in justifying centuries of violence against nonhuman animals. To help learners understand this vicious circle, Paul introduces a method that can be used in various educational contexts, at different levels, and with learners of all ages. The approach to teaching HAS that he proposes allows learners to reconsider how language and power work through the figure of the animal and to develop the ability to think intersectionally. Particularly in an age of numerous political and environmental crises, there is an urgent need for pedagogical interventions such as the one proposed by Paul.
A webinar series that was organised by the Academy of Pharmaceutical Sciences Biopharmaceutics focus group in 2021 focused on the challenges of developing clinically relevant dissolution specifications (CRDSs) for oral drug products. Industrial scientists, together with regulatory and academic scientists, came together through a series of six webinars, to discuss progress in the field, emerging trends, and areas for continued collaboration and harmonisation. Each webinar also hosted a Q&A session where participants could discuss the shared topic and information. Although it was clear from the presentations and Q&A sessions that we continue to make progress in the field of CRDSs and the utility/success of PBBM, there is also a need to continue the momentum and dialogue between the industry and regulators. Five key areas were identified which require further discussion and harmonisation.